Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report

Peer Review reports

Original Submission
2 Sep 2022	Submitted	Original manuscript
16 Feb 2023	Reviewed	Reviewer Report - Prabal Chourasia
25 Feb 2023	Reviewed	Reviewer Report - Harshal Parekh
17 Mar 2023	Author responded	Author comments - Karl Ciuoderis
Resubmission - Version 2
17 Mar 2023	Submitted	Manuscript version 2
Publishing
22 Mar 2023	Editorially accepted
4 May 2023	Article published	10.1186/s13256-023-03904-2

Back to article page